These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

484 related items for PubMed ID: 30755341

  • 1. Contemporary use and survival after perioperative systemic chemotherapy in patients with locally advanced non-metastatic urothelial carcinoma of the bladder treated with radical cystectomy.
    Mazzone E, Nazzani S, Knipper S, Tian Z, Preisser F, Gallina A, Soulières D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.
    Eur J Surg Oncol; 2019 Jul; 45(7):1253-1259. PubMed ID: 30755341
    [Abstract] [Full Text] [Related]

  • 2. Increasing Rates of Perioperative Chemotherapy are Associated With Improved Survival in Men With Urothelial Bladder Cancer With Prostatic Stromal Invasion.
    Rosiello G, Knipper S, Palumbo C, Pecoraro A, Luzzago S, Deuker M, Tian Z, Gandaglia G, Gallina A, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
    Clin Genitourin Cancer; 2020 Feb; 18(1):35-44.e1. PubMed ID: 31711842
    [Abstract] [Full Text] [Related]

  • 3. Survival effect of perioperative systemic chemotherapy on overall mortality in locally advanced and/or positive regional lymph node non-metastatic urothelial carcinoma of the upper urinary tract.
    Nazzani S, Preisser F, Mazzone E, Tian Z, Mistretta FA, Shariat SF, Soulières D, Saad F, Montanari E, Luzzago S, Briganti A, Carmignani L, Karakiewicz PI.
    World J Urol; 2019 Jul; 37(7):1329-1337. PubMed ID: 30298285
    [Abstract] [Full Text] [Related]

  • 4. Is neoadjuvant chemotherapy for pT2 bladder cancer associated with a survival benefit in a population-based analysis?
    Mazzone E, Knipper S, Mistretta FA, Tian Z, Preisser F, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Wisnivesky J, Karakiewicz PI.
    Cancer Epidemiol; 2019 Feb; 58():83-88. PubMed ID: 30528834
    [Abstract] [Full Text] [Related]

  • 5. Neoadjuvant Radiotherapy Improves Survival in Patients With T2b/T3 Bladder Cancer: A Population-Based Analysis.
    Diaz DA, Pollack A, Reis IM, Mahmoud O, Gonzalgo ML, Ishkanian A, Fernandez G, Manoharan M, Abramowitz MC.
    Clin Genitourin Cancer; 2015 Aug; 13(4):378-384.e1. PubMed ID: 25907230
    [Abstract] [Full Text] [Related]

  • 6. Radical cystectomy plus chemotherapy in patients with pure squamous cell bladder carcinoma: a population-based study.
    Rosiello G, Pecoraro A, Palumbo C, Knipper S, Luzzago S, Deuker M, Tian Z, Gandaglia G, Fossati N, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
    World J Urol; 2021 Mar; 39(3):813-822. PubMed ID: 32424515
    [Abstract] [Full Text] [Related]

  • 7. Partial Cystectomy With Pelvic Lymph Node Dissection for Patients With Nonmetastatic Stage pT2-T3 Urothelial Carcinoma of Urinary Bladder: Temporal Trends and Survival Outcomes.
    Mistretta FA, Cyr SJ, Luzzago S, Mazzone E, Knipper S, Palumbo C, Tian Z, Nazzani S, Saad F, Montanari E, Tilki D, Briganti A, Shariat SF, de Cobelli O, Karakiewicz PI.
    Clin Genitourin Cancer; 2020 Apr; 18(2):129-137.e3. PubMed ID: 32001182
    [Abstract] [Full Text] [Related]

  • 8. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis.
    Vetterlein MW, Seisen T, May M, Nuhn P, Gierth M, Mayr R, Fritsche HM, Burger M, Novotny V, Froehner M, Wirth MP, Protzel C, Hakenberg OW, Roghmann F, Palisaar RJ, Noldus J, Pycha A, Bastian PJ, Trinh QD, Xylinas E, Shariat SF, Rink M, Chun FK, Dahlem R, Fisch M, Aziz A, PROMETRICS 2011 Study Group.
    Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775
    [Abstract] [Full Text] [Related]

  • 9. Differential effect on survival of pelvic lymph node dissection at radical cystectomy for muscle invasive bladder cancer.
    Larcher A, Sun M, Schiffmann J, Tian Z, Shariat SF, McCormack M, Saad F, Fossati N, Abdollah F, Briganti A, Buffi N, Graefen M, Guazzoni G, Montorsi F, Karakiewicz PI.
    Eur J Surg Oncol; 2015 Mar; 41(3):353-60. PubMed ID: 25477269
    [Abstract] [Full Text] [Related]

  • 10. More Extensive Lymph Node Dissection Improves Survival Benefit of Radical Cystectomy in Metastatic Urothelial Carcinoma of the Bladder.
    Mazzone E, Preisser F, Nazzani S, Tian Z, Fossati N, Gandaglia G, Gallina A, Soulieres D, Tilki D, Montorsi F, Shariat SF, Saad F, Briganti A, Karakiewicz PI.
    Clin Genitourin Cancer; 2019 Apr; 17(2):105-113.e2. PubMed ID: 30527745
    [Abstract] [Full Text] [Related]

  • 11. Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.
    Necchi A, Pond GR, Smaldone MC, Pal SK, Chan K, Wong YN, Viterbo R, Sonpavde G, Harshman LC, Crabb S, Alva A, Chowdhury S, De Giorgi U, Srinivas S, Agarwal N, Bamias A, Baniel J, Golshayan AR, Ladoire S, Sternberg CN, Cerbone L, Yu EY, Bellmunt J, Vaishampayan U, Niegisch G, Hussain S, Bowles DW, Morales-Barrera R, Milowsky MI, Theodore C, Berthold DR, Sridhar SS, Powles T, Rosenberg JE, Galsky MD, Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).
    Eur Urol Focus; 2018 Dec; 4(6):937-945. PubMed ID: 28753879
    [Abstract] [Full Text] [Related]

  • 12. Trends and appropriateness of perioperative chemotherapy for muscle-invasive bladder cancer.
    Macleod LC, Yabes JG, Yu M, Fam MM, Hale NE, Turner RM, Lopa SH, Gingrich JR, Borza T, Skolarus TA, Davies BJ, Jacobs BL.
    Urol Oncol; 2019 Jul; 37(7):462-469. PubMed ID: 31053530
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Blood transfusions during neoadjuvant chemotherapy for muscle-invasive urinary bladder cancer may have a negative impact on overall survival.
    Rosenblatt R, Lorentzi G, Bahar M, Asad D, Forsman R, Johansson M, Shareef M, Alamdari F, Bergh A, Winqvist O, Sherif A.
    Scand J Urol; 2020 Feb; 54(1):46-51. PubMed ID: 31960752
    [Abstract] [Full Text] [Related]

  • 15. Impact of adjuvant chemotherapy in patients with adverse features and variant histology at radical cystectomy for muscle-invasive carcinoma of the bladder: Does histologic subtype matter?
    Berg S, D'Andrea D, Vetterlein MW, Cole AP, Fletcher SA, Krimphove MJ, Marchese M, Lipsitz SR, Sonpavde G, Noldus J, Shariat SF, Kibel AS, Trinh QD, Mossanen M.
    Cancer; 2019 May 01; 125(9):1449-1458. PubMed ID: 30620387
    [Abstract] [Full Text] [Related]

  • 16. How cancer-specific mortality changes over time after radical cystectomy: Conditional survival of patients with nonmetastatic urothelial carcinoma of the urinary bladder.
    Palumbo C, Mistretta FA, Knipper S, Pecoraro A, Tian Z, Shariat SF, Saad F, Simeone C, Briganti A, Antonelli A, Karakiewicz PI.
    Urol Oncol; 2019 Dec 01; 37(12):893-899. PubMed ID: 31296422
    [Abstract] [Full Text] [Related]

  • 17. Oncological outcomes of advanced muscle-invasive bladder cancer with a micropapillary variant after radical cystectomy and adjuvant platinum-based chemotherapy.
    Masson-Lecomte A, Xylinas E, Bouquot M, Sibony M, Allory Y, Comperat E, Zerbib M, de la Taille A, Rouprêt M.
    World J Urol; 2015 Aug 01; 33(8):1087-93. PubMed ID: 25179011
    [Abstract] [Full Text] [Related]

  • 18. Management Trends and Outcomes of Patients Undergoing Radical Cystectomy for Urothelial Carcinoma of the Bladder: Evolution of the University of Southern California Experience over 3,347 Cases.
    Mitra AP, Cai J, Miranda G, Bhanvadia S, Quinn DI, Schuckman AK, Djaladat H, Daneshmand S.
    J Urol; 2022 Feb 01; 207(2):302-313. PubMed ID: 34994657
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.